For research use only. Not for therapeutic Use.
Gemnelatinib is a tyrosine kinase inhibitor (WO2018077227, implementation example 1). Gemnelatinib can be used for the research of cancer[1].
Gemnelatinib is a tyrosine kinase inhibitor[1]
| Catalog Number | I028000 |
| CAS Number | 2225123-30-6 |
| Synonyms | 2-[5-fluoro-1-[(1R)-1-[3-[5-[(1-methylpiperidin-4-yl)methoxy]pyrimidin-2-yl]phenyl]ethyl]-6-oxopyridin-3-yl]pyridine-4-carbonitrile |
| Molecular Formula | C30H29FN6O2 |
| Purity | ≥95% |
| InChI | InChI=1S/C30H29FN6O2/c1-20(37-18-25(14-27(31)30(37)38)28-12-22(15-32)6-9-33-28)23-4-3-5-24(13-23)29-34-16-26(17-35-29)39-19-21-7-10-36(2)11-8-21/h3-6,9,12-14,16-18,20-21H,7-8,10-11,19H2,1-2H3/t20-/m1/s1 |
| InChIKey | UDDRTVZAZBIBBN-HXUWFJFHSA-N |
| SMILES | CC(C1=CC=CC(=C1)C2=NC=C(C=N2)OCC3CCN(CC3)C)N4C=C(C=C(C4=O)F)C5=NC=CC(=C5)C#N |
| Reference | [1]. WO2018077227 |
